The Cutting Edge of Cancer Innovation

Oncolytics Biotech Inc. is a developer of oncolytic viruses as cancer therapeutics and is listed on the Toronto Stock Exchange (TSX:ONC), the OTCQX® Best Market (OTCQX:ONCYF) and the Frankfurt Stock Exchange (FRA:ONY). In addition to the information available on this site, investors can access the Company’s regulatory filings on the SEDAR website at www.sedar.com and on the EDGAR website at www.sec.gov.

Stock Information

Exchange Price
TSX: ONC $ CAD
OTCQX: ONCYF $ USD
FRA: ONY $ EUR

VIEW ALL STOCK INFORMATION

Financials

Access our quarterly and year-end financial statements, MD&A, information circulars and annual reports.

2016 First Quarter Financial Report

VIEW ALL FINANCIALS

Corporate Governance

Oncolytics Biotech Inc. believes in a transparent and forward-facing approach to business.

VIEW ALL DOCUMENTS